2016 AAPM Annual Meeting
Back to session list

Session Title: Big Data in Radiation Oncology
Question 1: Big Data will have what impact on Patient Health Information:
Reference:Kevin L. Moore, George C. Kagadis, Todd R. McNutt, Vitali Moiseenko, and Sasa Mutic, “Automation and Advanced Computing in Clinical Radiation Oncology” Med Phys 41, 010901 (2014)
Choice A:Resolve all of the PHI issues by providing more open access.
Choice B:Partition PHI from institutional access by use of cloud computing.
Choice C:Remove PHI as an issue of concern.
Choice D:Provide an increase in complexity for PHI that will require greater diligence to ensure patient privacy.
Question 2: Development of the Radiation Oncology Incident learning System (ROILS) has several advantages, EXCEPT:
Reference:Overview of the ASTRO-NIH-AAPM Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data, Stanley H. Benedict, PhD (Chair), Karen Hoffman, MD (Co-Chair),Mary K. Martel, PhD, et al, In Press Int Jo Radiat Oncol Biol Phys
Choice A:It allows institutions to share their “close calls” in potential misadministrations.
Choice B:Provides a means to review actual incidents that have led to unintended radiation doses to the patient.
Choice C:Is a searchable database that can identify issues with specific technology and techniques.
Choice D:Ensures that PHI is secure and confidential according to established guidelines.
Question 3: The proposed national radiation oncology registry has several advantages, EXCEPT:
Reference:Overview of the ASTRO-NIH-AAPM Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data, Stanley H. Benedict, PhD (Chair), Karen Hoffman, MD (Co-Chair),Mary K. Martel, PhD, et al, In Press Int Jo Radiat Oncol Biol Phys
Choice A:Provide a wider opportunity to pool patients for clinical research analysis from diverse patient populations, geography, and institutions.
Choice B:Potentially allows a mechanism for data mining and “virtual” clinical research analysis.
Choice C:Helps to foster the mission of learning as much as possible from our patients in the goal of providing precision medicine.
Choice D:Allows patients to enroll themselves into clinical protocols.
Question 4: Knowledge based treatment planning has many advantages, EXCEPT:
Reference:McNutt T., Moore K., Quon H. “Needs and Challenges for Big Data in Radiation Oncology,” Int’l J. of Radiation Oncology, Biology, Physics. Published online: November 27 2015
Choice A:Allows treatment plans for various disease sites to be compared to many other similar plans.
Choice B:Is a personalized method for treatment planning.
Choice C:Can include adverse effects of radiation on normal tissues.
Choice D:Ensures that PHI is secure and confidential according to established guidelines.
Question 5: Which answer is not a major challenge for the implementation of Learning Health Systems for Radiation Oncology?
Reference:McNutt T., Moore K., Quon H. “Needs and Challenges for Big Data in Radiation Oncology,” Int’l J. of Radiation Oncology, Biology, Physics. Published online: November 27 2015
Choice A:Clinical culture and documentation to support the quantification of the patient condition.
Choice B:Database technology to enable large scale access to complex RT data.
Choice C:Data science models that can predict outcomes and are consistent with existing knowledge.
Choice D:Data completeness and integrity .
Question 6: Radiomics is an emerging field of research and promises to advance significantly patient care. All of the following are true, EXCEPT
Reference:Gillies R.J., Kinahan P.E., Hricak H., Radiomics: Images Are More than Pictures, They Are Data, Radiology. 2016 Feb;278(2):563-577.
Choice A:It uses a large amount of imaging data for prognostic prediction of outcome of the patients.
Choice B:It quantifies tumor phenotypic characteristics by applying feature algorithms to imaging data.
Choice C:It is used in current knowledge based treatment planning.
Choice D:It represents a significant component of big data initiatives aimed at drawing inferences from large data sets that are not derived from carefully controlled experiments.
Back to session list